Reports - Theranostics Market
HealthcareTheranostics Market
Theranostics Market Growth and Trends | Insights & Forecast 2025-2035 by Products (Diagnostic Imaging, Radiopharmaceuticals, IVD/Biomarker Screening, Software and Services) by Application (Prostate Cancer, Bone Metastasis, Others) by End User (Hospitals and Cancer Care Centers, Theranostics Centers, Research and Academic Centers) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Theranostics Market - Segment Analysis
1. Overview
2. Global Theranostics Market, 2021 - 2035 (USD Million)
3. Global Theranostics Market - by Products
3.1. By Diagnostic Imaging
3.2. By Radiopharmaceuticals
3.3. By IVD/Biomarker Screening
3.4. By Software & Services
4. Global Theranostics Market - by Application
4.1. By Prostate Cancer
4.2. By Bone Metastasis
4.3. By Other Applications
5. Global Theranostics Market - by End User
5.1. By Hospitals & Cancer Care Centers
5.2. By Theranostics Centers
5.3. By Research & Academic Centers
6. Global Theranostics Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4 North America Theranostics Market - Segment Analysis
1. Overview
2. North America Theranostics Market, 2021 - 2035 (USD Million)
3. North America Theranostics Market - by Products
3.1. By Diagnostic Imaging
3.2. By Radiopharmaceuticals
3.3. By IVD/Biomarker Screening
3.4. By Software & Services
4. North America Theranostics Market - by Application
4.1. By Prostate Cancer
4.2. By Bone Metastasis
4.3. By Other Applications
5. North America Theranostics Market - by End User
5.1. By Hospitals & Cancer Care Centers
5.2. By Theranostics Centers
5.3. By Research & Academic Centers
Chapter 5 Europe Theranostics Market - Segment Analysis
1. Overview
2. Europe Theranostics Market, 2021 - 2035 (USD Million)
3. Europe Theranostics Market - by Products
3.1. By Diagnostic Imaging
3.2. By Radiopharmaceuticals
3.3. By IVD/Biomarker Screening
3.4. By Software & Services
4. Europe Theranostics Market - by Application
4.1. By Prostate Cancer
4.2. By Bone Metastasis
4.3. By Other Applications
5. Europe Theranostics Market - by End User
5.1. By Hospitals & Cancer Care Centers
5.2. By Theranostics Centers
5.3. By Research & Academic Centers
Chapter 6 Asia Pacific Theranostics Market - Segment Analysis
1. Overview
2. Asia Pacific Theranostics Market, 2021 - 2035 (USD Million)
3. Asia Pacific Theranostics Market - by Products
3.1. By Diagnostic Imaging
3.2. By Radiopharmaceuticals
3.3. By IVD/Biomarker Screening
3.4. By Software & Services
4. Asia Pacific Theranostics Market - by Application
4.1. By Prostate Cancer
4.2. By Bone Metastasis
4.3. By Other Applications
5. Asia Pacific Theranostics Market - by End User
5.1. By Hospitals & Cancer Care Centers
5.2. By Theranostics Centers
5.3. By Research & Academic Centers
Chapter 7 Latin America Theranostics Market - Segment Analysis
1. Overview
2. Latin America Theranostics Market, 2021 - 2035 (USD Million)
3. Latin America Theranostics Market - by Products
3.1. By Diagnostic Imaging
3.2. By Radiopharmaceuticals
3.3. By IVD/Biomarker Screening
3.4. By Software & Services
4. Latin America Theranostics Market - by Application
4.1. By Prostate Cancer
4.2. By Bone Metastasis
4.3. By Other Applications
5. Latin America Theranostics Market - by End User
5.1. By Hospitals & Cancer Care Centers
5.2. By Theranostics Centers
5.3. By Research & Academic Centers
Chapter 8 Middle East & Africa Theranostics Market - Segment Analysis
1. Overview
2. Middle East & Africa Theranostics Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Theranostics Market - by Products
3.1. By Diagnostic Imaging
3.2. By Radiopharmaceuticals
3.3. By IVD/Biomarker Screening
3.4. By Software & Services
4. Middle East & Africa Theranostics Market - by Application
4.1. By Prostate Cancer
4.2. By Bone Metastasis
4.3. By Other Applications
5. Middle East & Africa Theranostics Market - by End User
5.1. By Hospitals & Cancer Care Centers
5.2. By Theranostics Centers
5.3. By Research & Academic Centers
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. GE Healthcare Technologies (U.S.)
2. BAMF Health (U.S.)
3. Siemens Healthcare AG (Germany)
4. Canon Medical Systems Corporation (Japan)
5. Curasight (Denmark)
6. Cardinal Health Inc. (U.S.)
7. Radiopharm Theranotics Ltd. (Australia)
8. Clarity Pharmaceuticals Ltd. (Australia)
9. Point Biopharma Global Inc. (U.S.)
10. Nuview Life Sciences (U.S.)
11.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By